Stock listing
OTC:GBIM Globeimmune Inc Stock
Follow Globeimmune Inc into a list and get an email when it puts out news.
Share price · OTC:GBIM
$0.0001 USD 0.0000 (0.0%)
Close on Nov 11, 2026
- Day range
- $0.0001 – $0.0001 USDNov 11, 2026
- Volume
- 2,062 sharesNov 11, 2026
- Market cap
- $575 USDAt the close on Nov 11, 2026 · price × 5.75M shares outstanding
- 52-week range
- $0.0001 – $0.0401 USDLowest and highest trades, Nov 12, 2025 – Nov 11, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 61 days with no trades · last 3 months, Aug 11, 2026 – Nov 11, 2026

Daily closes
Last 3 months, Aug 11, 2026 – Nov 11, 2026 · OTC:GBIM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 2,062 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 300 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 12,537 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 3,775 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 35,900 | |
| $0.0001 | 0.0000 | 0.0% | — | $0.0001 | — | 756 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 |
- Ticker
- OTC:GBIM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Globeimmune Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 2 decks · latest Jun 30, 2014
Valuation
price Nov 11, 2026
- Enterprise value
- No statements on 6ix yet
- P/E
- No statements on 6ix yet
- EV/sales
- No statements on 6ix yet
- EV/EBITDA
- No statements on 6ix yet
- Price/book
- No statements on 6ix yet
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.00
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Globeimmune Inc · OTC:GBIM | US$575 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 |
| Chimeric Therapeutics Limited · ASX:CHM | US$292,816 | −US$220,193 | n/a | −0.1× | n/a | 0.2× | −262.8% | 2.5× | n/a |
| CERo Therapeutics Holdings, Inc. · OTC:CERO | US$265,035 | −US$190,890 | n/a | n/a | n/a | n/a | n/a | n/a | 1.47 |
| CDT Equity Inc. · NASDAQ:CDT | US$234,109 | −US$1.49M | n/a | n/a | n/a | 0.0× | n/a | 0.0× | 1.14 |
| GlucoTrack, Inc. · NASDAQ:GCTK | US$217,049 | −US$887,951 | n/a | n/a | n/a | n/a | n/a | n/a | 1.73 |
| Regen BioPharma, Inc. · OTC:RGBP | US$167,528 | US$167,289 | n/a | 0.7× | n/a | n/a | −501.4% | n/a | 1.20 |
| CNBX Pharmaceuticals Inc. · OTC:CNBX | US$160,577 | US$151,090 | n/a | n/a | n/a | n/a | n/a | n/a | 1.78 |
| Fifty 1 Labs Inc. · OTC:FITY | US$118,532 | US$282,021 | n/a | 6,000× | n/a | n/a | n/a | n/a | -1.17 |
| GB Sciences, Inc. · OTC:GBLX | US$81,414 | US$2.07M | n/a | n/a | n/a | n/a | n/a | n/a | -0.46 |
| Lyra Therapeutics, Inc. · OTC:LYRA | US$53,246 | US$14.42M | n/a | 36.2× | n/a | n/a | n/a | n/a | 0.67 |
| ZyVersa Therapeutics, Inc. · OTC:ZVSA | US$810 | US$1.20B | n/a | n/a | n/a | n/a | n/a | n/a | -0.56 |
| Median of the others | US$164,053 | US$159,190 | 18.5× | 0.1× | −382.1% | 1.3× | 1.14 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (June 2014) | IPO roadshow | 35 slides | Jun 30, 2014 |
| IPO Roadshow (June 2014) | IPO roadshow | 28 slides | Jun 12, 2014 |
Financials
Annual, in USD
Income statement
| Line | FY2022 | FY2021 | FY2020 | FY2019 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.46M | 5.97M | 22.5M | 14.6M | 5.11M | 4.07M | ||||
| Cost of revenue | 2.65M | 4.99M | 9.02M | 10.0K | ||||||
| Gross profit | 3.81M | 974.2K | 13.5M | 14.6M | 5.11M | 4.07M | ||||
| Research and development | 4.48M | 7.21M | 10.9M | 11.7M | 12.1M | 14.1M | ||||
| Selling, general and administrative | 4.55M | 4.28M | 3.17M | 5.95M | 4.36M | |||||
| Operating income | -2.77M | -5.82M | 7.69M | -3.97M | -12.6M | -15.8M | ||||
| Depreciation and amortization | 228.5K | 236.6K | 206.3K | 171.9K | 187.3K | 295.2K | 771.3K | 925.5K | 952.1K | 1.32M |
| EBITDA | -2.58M | -5.52M | 8.46M | -3.04M | -11.6M | -14.4M | ||||
| Interest expense | 0 | 3.89M | 1.90M | 0 | ||||||
| Income before tax | -2.77M | -16.3M | 9.59M | -2.01M | -13.7M | -14.8M | ||||
| Income tax | 200.0K | 3.89M | 115.8K | -1.95M | 1.13M | -952.9K | ||||
| Net income | -2.77M | -20.2M | 9.48M | -2.01M | -14.9M | -14.8M | ||||
| Earnings per share, basic | -0.48 | -6.91 | 99.11 | -21.07 | -155.37 | -154.69 |
Balance sheet
| Line | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 9.90M | 16.8M | 5.92M | 2.00M | 15.2M | 20.3M |
| Short-term investments | 0 | 0 | 0 | 0 | ||
| Inventory | 0 | 0 | 0 | 0 | ||
| Current assets | 11.1M | 17.8M | 6.83M | 2.89M | 15.6M | 20.7M |
| Property, plant and equipment | 209.7K | 455.8K | 492.8K | 1.25M | ||
| Goodwill | 0 | 0 | 0 | 0 | ||
| Total assets | 11.5M | 18.4M | 7.42M | 4.24M | 17.7M | 23.7M |
| Accounts payable | 234.1K | 572.6K | 1.74M | 2.96M | 1.31M | 1.13M |
| Current liabilities | 4.23M | 5.17M | 6.41M | 8.35M | 13.4M | 6.40M |
| Long-term debt | 0 | 0 | 198.0K | 0 | ||
| Total debt | 921.0K | |||||
| Total liabilities | 8.52M | 12.8M | 206.7M | 200.4M | 200.1M | 181.4M |
| Shareholders' equity | 2.99M | 5.60M | -199.3M | -196.1M | -182.4M | -157.7M |
| Shares outstanding | 5.75M | 2.91M | 95.6K | 95.6K | 95.6K | 95.6K |
Cash flow
| Line | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|
| Cash from operations | -7.13M | -10.1M | 3.93M | -13.1M | -5.01M | -17.8M |
| Capital spending | -35.7K | -294.2K | -12.2K | -108.8K | -132.8K | -2.38M |
| Free cash flow | -7.17M | -10.3M | 3.92M | -13.2M | -5.14M | -20.2M |
| Cash from investing | 218.0K | -166.8K | -12.2K | -108.8K | -132.8K | -2.33M |
| Cash from financing | 0 | 21.1M | 1.80K | 25.2K | 1.02K | 17.9M |
| Dividends paid | 0 | 0 | 0 | 0 | ||
| Share buybacks | 0 | 144.1M | 7.04M | 34.1M | ||
| Change in cash | -6.91M | 10.9M | 3.92M | -13.2M | -5.14M | -2.23M |
Cap table
Built by 6ix from Globeimmune Inc’s releases
- Common shares
- 5,751,574
- Fully diluted
- 5,751,574
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,751,574 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,751,574 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Augustine Lawlor Other companies: PRF Technologies Ltd. (Director · Since at least Mar 18, 2026); Cypherpunk Technologies Inc. (Chief Operating Officer · Since at least Jan 20, 2017); Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Aug 31, 2023 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Apr 27, 2023 · Past); Human Genome Sciences Inc (Director · Oct 10, 2011 – Jul 30, 2012 · Past) | Director · Jul 1, 2014 – Mar 18, 2016 · Past |
| J William Freytag | Director · Jul 1, 2014 – Jul 9, 2015 · Past |
| Pennina Safer | Director · Jul 1, 2014 – Sep 30, 2014 · Past |
Log in to ask 6ix AI your own questions about Globeimmune Inc.